Q4 2024 Holdings
Filed 2025-02-14 | 37 holdings | $279.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $22.2M | 494,424 | 7.9% |
| Merus N V | COM | N5749R100 | $19.5M | 463,840 | 7.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $18.4M | 219,719 | 6.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $17.6M | 229,785 | 6.3% |
| Novo-Nordisk A S(NVO)Put | ADR | 670100205 | $17.2M | 200,000 | 6.1% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $17.2M | 200,000 | 6.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $16.0M | 204,045 | 5.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $13.3M | 162,255 | 4.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $13.3M | 56,400 | 4.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $12.5M | 190,752 | 4.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $12.4M | 284,190 | 4.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $11.9M | 255,318 | 4.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $11.6M | 167,939 | 4.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $11.3M | 293,851 | 4.1% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $9.0M | 100,000 | 3.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $8.7M | 162,976 | 3.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $7.0M | 11,311 | 2.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.1M | 45,000 | 2.2% |
| Novo-Nordisk A S(NVO)Call | ADR | 670100205 | $4.3M | 50,000 | 1.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.6M | 90,279 | 1.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.8M | 50,000 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.3M | 45,765 | 0.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $2.3M | 102,900 | 0.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.9M | 53,930 | 0.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.9M | 100,000 | 0.7% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $1.6M | 54,515 | 0.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.6M | 216,700 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.6M | 40,000 | 0.6% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.5M | 421,359 | 0.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.4M | 54,285 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.3M | 80,380 | 0.5% |
| Edgewise Therapeutics Inc(EWTX)Put | COM | 28036F105 | $1.3M | 50,000 | 0.5% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $1.2M | 6,305 | 0.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.2M | 20,811 | 0.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.0M | 7,440 | 0.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $883.5K | 172,226 | 0.3% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $768.7K | 16,650 | 0.3% |